According to the company's statement, Labcorp was involved in the development of over 80  of the new drugs approved by the FDA in 2022 and conducted more than 600 million tests for patients globally. BURLINGTON, N.C. - Laboratory Corporation of America Holdings  NYSE  NYSE LH , commonly known as Labcorp, has declared a quarterly cash dividend of $0.72 per share on its common stock. The dividend is scheduled to be paid on March 13, 2024, to shareholders who are on the record by the close of business on February 27, 2024.Labcorp is recognized as a prominent player in the life sciences industry, providing a range of laboratory services that support physicians, hospitals, pharmaceutical entities, researchers, and patients. Labcorp's operations encompass diagnostics and drug development laboratory services that contribute to the healthcare landscape. Labcorp's announcement is based on a press release statement and is intended to inform shareholders and the broader financial community of the upcoming dividend payment.
Labcorp, a leading life sciences company, contributed to the development of over 80 FDA-approved drugs in 2022 and conducted over 600 million tests globally.